1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Doxorubicin Market – By Drug Formulation

1.3.2        SAM Doxorubicin Market – By Application

1.3.3        SAM Doxorubicin Market – By Distribution Channel

1.3.4        SAM Doxorubicin Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Doxorubicin Market – Market Landscape

4.1         Overview

4.2         SAM PEST Analysis

4.3         Expert Opinion

5.           SAM Doxorubicin Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Increasing Preference for Chemotherapy

5.2         Market Restraints

5.2.1        Potential Side-effects Associated with Doxorubicin

5.3         Market Opportunities

5.3.1        Increasing Government Funding, Guidance, and Technical Assistance for Cancer Prevention

5.4         Future Trends

5.4.1        Increasing Approval of Generic Products

5.5         Impact Analysis

6.           Doxorubicin Market– SAM Analysis

6.1         SAM Doxorubicin Market Revenue Forecast and Analysis

7.           SAM Doxorubicin Market Analysis – By Drug Formulation

7.1         Overview

7.2         SAM Doxorubicin Market Share, By Drug Formulation 2022 & 2028 (%)

7.3         Lyophilized Powder

7.3.1        Overview

7.3.2        Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

7.4         Doxorubicin Injection

7.4.1        Overview

7.4.2        Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.           SAM Doxorubicin Market Analysis – By Application

8.1         Overview

8.2         SAM Doxorubicin Market Share, By Application 2022 & 2028 (%)

8.3         Breast Cancer

8.3.1        Overview

8.3.2        Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.4         Kidney Cancer

8.4.1        Overview

8.4.2        Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.5         Liver Cancer

8.5.1        Overview

8.5.2        Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.6         Sarcoma

8.6.1        Overview

8.6.2        Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.7         Ovarian Cancer

8.7.1        Overview

8.7.2        Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.8         Lung Cancer

8.8.1        Overview

8.8.2        Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.9         Leukemia

8.9.1        Overview

8.9.2        Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.10      Multiple Myeloma

8.10.1     Overview

8.10.2     Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

8.11      Others

8.11.1     Overview

8.11.2     Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.           SAM Doxorubicin Market Analysis – By Disribution Channel

9.1         Overview

9.2         SAM Doxorubicin Market Share, By Disribution Channel 2022 & 2028 (%)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

9.5         Online Pharmacy

9.5.1        Overview

9.5.2        Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

10.        SAM Doxorubicin Market Analysis – By Country

10.1      Overview

10.1.1     SAM: Doxorubicin Market, by Country, 2022 & 2028 (%)

10.1.1.1       Brazil: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Brazil: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       Brazil: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)

10.1.1.1.4       Brazil: Doxorubicin Market, by Application, 2019–2028 (US$ Million)

10.1.1.1.5       Brazil: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)

10.1.1.2       Argentina: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Argentina: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       Argentina: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)

10.1.1.2.4       Argentina: Doxorubicin Market, by Application, 2019–2028 (US$ Million)

10.1.1.2.5       Argentina: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)

10.1.1.3       Rest of South and Central America: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       Rest of SAM: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       Rest of SAM: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)

10.1.1.3.4       Rest of SAM: Doxorubicin Market, by Application, 2019–2028 (US$ Million)

10.1.1.3.5       Rest of SAM: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Accord Healthcare

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Cipla Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Dr. Reddy's Laboratories

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Meiji Holdings Co., Ltd.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Novartis AG

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Pfizer Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Sun Pharmaceutical Industries Ltd

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Baxter International Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Zydus Cadila

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             SAM Doxorubicin Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             Brazil: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Brazil: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Brazil Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Argentina Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Argentina Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Argentina Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Rest of SAM: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Rest of SAM: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Rest of SAM Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Organic Developments Done By Companies

Table 12.          Inorganic Developments Done by Companies

Table 13.          Glossary of Terms

LIST OF FIGURES

Figure 1.           SAM Doxorubicin Market Segmentation

Figure 2.           SAM Doxorubicin Market Segmentation, By Country

Figure 3.           SAM Doxorubicin Market Overview

Figure 4.           SAM Doxorubicin Market, By Drug Formulation

Figure 5.           SAM Doxorubicin Market, By Country

Figure 6.           SAM: PEST Analysis

Figure 7.           SAM Doxorubicin Market Impact Analysis Of Driver And Restraints

Figure 8.           SAM Doxorubicin Market– Revenue Forecast and Analysis

Figure 9.           SAM Doxorubicin Devices Market Share, By Drug Formulation 2022 & 2028 (%)

Figure 10.        SAM Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 11.        SAM Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 12.        SAM Doxorubicin Devices Market Share, By Application 2022 & 2028 (%)

Figure 13.        SAM Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 14.        SAM Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 15.        SAM Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 16.        SAM Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 17.        SAM Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 18.        SAM Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 19.        SAM Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 20.        SAM Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 21.        SAM Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 22.        SAM Doxorubicin Devices Market Share, By Disribution Channel 2022 & 2028 (%)

Figure 23.        SAM Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 24.        SAM Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 25.        SAM Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)

Figure 26.        SAM: Doxorubicin Market, By Key Country – Revenue (2022) (US$ Million)

Figure 27.        SAM: Doxorubicin Market, by Country, 2022 & 2028 (%)

Figure 28.        Brazil: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Argentina: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Rest of SAM: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)